Meet Rhea, Real FEIBA [Anti-Inhibitor Coagulant Complex] Patient

Patient Stories

Meet Rhea

Caregiver
Super Mom
Hemophilia
Walks
My husband, Timothy, and I are parents of 2 wonderful children, Timmy and Timea.
What’s your experience with hemophilia and inhibitors?
When Timmy was born, he was diagnosed with severe hemophilia A; when he was 7 months old, he was discovered to have inhibitors.
My family has a long history of hemophilia. My uncle and a few of my cousins have had hemophilia. When I was 16 and had prolonged, uncontrolled bleeding after a tonsillectomy, my doctors told me I was a symptomatic carrier. At age 31, I was diagnosed with mild hemophilia.
Clearly, hemophilia is not a foreign world to me, but inhibitors were.
Tell us about Timmy’s treatment journey.
When Timmy was 7 months old, the doctors recommended inserting a port. It made infusions easier until it became infected. The port had to be removed. Timmy was treated with antibiotics and another catheter was inserted. That worked well until he pulled it out after a bath. After that, the doctor put in a peripherally inserted central catheter—a PICC—in his arm.
Timmy had frequent bleeds and was in the hospital nearly every weekend. His first really bad bleed was a knee bleed that developed when he started crawling. When he was 3, another port was inserted; he has had it since then.
Timmy is now on prophylactic treatment with FEIBA [Anti-Inhibitor Coagulant Complex] per his doctor’s recommendation. This has made a huge difference in Timmy’s life and all of ours. He doesn’t experience nearly as many bleeds. He has gone from being in the hospital nearly every weekend to only going a few times a year.

“Because of FEIBA prophylactic treatment, my Timmy can live his life with so much less worry about bleeds.”

With FEIBA prophylactic treatment, Timmy has more time to be active. Being able to run around and play is what a little boy like Timmy needs and deserves. It builds up his strength and confidence.
How do you and your family manage Timmy's inhibitors?
It has been a great help for me to have an Associate’s Degree as a Medical Assistant. I had already been formally trained to infuse, so I can infuse Timmy when I need to.
It was hard to know when Timmy had a bleed as a baby. He rarely cries or complains about anything. Bleeding was really only evident when I saw swelling or bruising. Now that Timmy is 10 years old, he describes his pain on a 10-point scale. Because of his nature, though, I know that his 5 is really any other person’s 9.
Timmy’s hemophilia has not held him back in school. I am so happy that we’ve been able to keep Timmy on track considering all the days of school that he missed.
When he was in 4th grade, we made sure Timmy was on an individualized education program, or IEP, which documents that he has a chronic illness, so the school can be more lenient with him when it comes to deadlines for homework and tests.
Aside from the limitations set by how often Timmy has been out of school, there are also the limitations of how he can play at school. Every year, someone from the hemophilia treatment center (HTC) comes out to the school to instruct teachers and nurses on how to treat Timmy if something should happen at school.
Between missing so much school, and not being able to play the same way that the other kids do, Timmy doesn’t have the best life at school. There is plenty of teasing because Timmy is different, and it is often frustrating for him.
How else do you and Timmy find support and inspiration?
Luckily, we have a huge family so Timmy has lots of friends and a very loving, supportive group for him at home.
Timmy sees his hematologist and nurses at the HTC once every 6 months. Once a year, he also sees a physical therapist who evaluates his joints and a social worker who talks to him about school and other kids and makes sure he is where he should be in maturity and understanding.

“Timmy is 150% boy. He seems to have boundless energy, running around every chance he gets.”

I’ve noticed from talking with other parents of children with hemophilia that a lot of their boys have the same kind of energy as Timmy. We like to harness that energy into fun, low-risk activities such as swimming and biking. We like to go for bike rides with his dad and sister. He also loves the playground.
We try to be sure that Timmy is as protected as he can be when he is playing, with a helmet and pads on when we go biking.
Are you involved with the community and camp?
“I like to help with the events.
I try to be an advocate for the newer members.”
I like being involved with the hemophilia community. When Timmy was 3, I started going to events. My family and I also like to participate in the fundraisers. Last year we got our church involved in a walk, and we had one of the biggest teams ever.
During discussions at community events, I like to step up and ask the questions that new parents might not be asking. The people in charge can count on me to help out and keep the conversation moving.

“Timmy went to hemophilia camp for the first time last year, and he was in love with it. It was amazing for him to be able to go out and play with no worries about other kids being too rough—everyone there knows what he’s going through.”

The activities at these hemophilia community events are specially chosen to be low risk. He loved being able to choose from all the options rather than having to limit himself. At camp he had the opportunity to see kids younger than him trying to learn to manage their hemophilia.
What have you learned from being a caregiver?
I have been around hemophilia my whole life, and I have been fortunate to see the advances in treatment options in the last few decades.

“One of the most significant things I have learned from having a child with a chronic illness is that not every setback is an unmanageable tragedy.”

I have learned not to “sweat the small stuff.” There is just so much going on in everyday life that any other problems, like drama at work, won’t even faze me anymore. Nothing is as challenging as what my loved ones and I have gone through.

Not all activities are appropriate for all people. Be sure to consult your physician or treatment center before beginning any exercise program or participating in sporting activities. If an injury occurs, contact your physician or treatment center immediately for the appropriate treatment.

You should be trained on how to do infusions by your hemophilia treatment center or your healthcare provider.

Using prophylaxis with FEIBA for his treatment routine helped Timmy lower his bleeds.

Swimming
Computer
Enthusiast
Camping

Meet Loren

See his story

Discover what it means to find your True Identity. Get involved in
meetings, and get inspired by patients and caregivers who share their
stories of managing bleeds.

Want to find other types of support? Check out our Tools & Resources section.

Go

FEIBA [Anti-Inhibitor Coagulant Complex]
Indications and Detailed Important Risk Information for Patients

Indications for FEIBA

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Use around the time of surgery
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

FEIBA is NOT for use in the treatment of bleeding episodes resulting from coagulation factor deficiencies without inhibitors to factor VIII or factor IX.

Detailed Important Risk Information for FEIBA

WARNING: EVENTS INVOLVING CLOTS THAT BLOCK BLOOD VESSELS

  • Blood clots that block blood vessels and their effects have been reported during post-marketing surveillance following infusion of FEIBA, particularly following administration of high doses (above 200 units per kg per day) and/or in patients at risk for forming blood clots.
  • If you experience any of these side effects, call your doctor right away.

Who should not use FEIBA?

You should not use FEIBA if:

  • You had a previous severe allergic reaction to the product
  • You have Disseminated Intravascular Coagulation (DIC), or signs of small blood vessel clots throughout the body
  • You have sudden blood vessel clots or blocked blood vessels, (such as, heart attack or stroke)

What other important information should I know about FEIBA?

Events involving blood clots blocking blood vessels (such as blood clot in vein, blood clot in the lung, heart attack, and stroke) can occur with FEIBA, particularly after receiving high doses (above 200 units per kg per day) and/or in patients with risk factors for clotting.

Events of thrombotic microangiopathy (TMA), a condition where blood clots and damage occur in small blood vessels, were reported in an emicizumab (Hemlibra®) clinical trial where patients received FEIBA with emicizumab as part of a treatment plan for breakthrough bleeding. The safety and efficacy of FEIBA for breakthrough bleeding in patients receiving emicizumab has not been established. If you take, or anticipate taking, FEIBA with emicizumab, tell your doctor, since they will need to closely monitor you.

At first sign or symptom of a sudden blood vessel clot or blocked blood vessel (such as chest pain or pressure, shortness of breath, fever, altered consciousness, vision, or speech, limb or abdomen swelling and/or pain), stop FEIBA administration right away and seek immediate emergency medical treatment.

Infusion of FEIBA should not exceed a single dose of 100 units per kg body weight and daily doses of 200 units per kg of body weight. Maximum injection or infusion rate must not exceed 2 units per kg of body weight per minute.

Allergic reactions, including severe, sometimes fatal allergic reactions that can involve the whole body, can occur following the infusion of FEIBA. Stop using FEIBA promptly and call your doctor or get emergency treatment right away if you get a rash, hives or welts, experience itching, tightness of the throat, vomiting, abdominal pain, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, nausea or fainting.

Because FEIBA is made from human plasma it may carry a risk of transmitting infectious agents, such as viruses, variant Creutzfeldt-Jakob disease (vCJD) and, theoretically, the Creutzfeldt-Jakob disease (CJD).

What are the possible side effects of FEIBA?

The most common side effects observed during the prophylaxis clinical study were low number of red blood cells, diarrhea, bleeding into a joint, positive test for hepatitis B surface antibodies, nausea, and vomiting.

The serious side effects seen with FEIBA are allergic reactions and clotting events involving blockage of blood vessels, which include stroke, blockage of the main blood vessel to the lung, and deep vein blood clots.

Call your doctor right away about any side effects that bother you during or after you stop taking FEIBA.

What other medications might interact with FEIBA?

Talk with your doctor about the possibility of formation of blood clots when taking drugs that may prevent clot breakdown such as tranexamic acid, and aminocaproic acid. There have not been adequate studies of the use of FEIBA and rFVIIa (NovoSeven®), or emicizumab together, or one after the other. Use of drugs that may prevent clot breakdown within approximately 6 to 12 hours after the administration of FEIBA is not recommended.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088

Please see FEIBA full Prescribing Information, including BOXED WARNING on blood clots, and discuss with your doctor.